(Q35158843)

6 August 2017

title

Cellular studies reveal mechanistic differences between taccalonolide A and paclitaxel (English)

1 reference

6 August 2017

1 reference

April L Risinger

1

1 reference

6 August 2017

Susan L Mooberry

series ordinal

2

1 reference

6 August 2017

publication date

1 July 2011

1 reference

6 August 2017

1 reference

6 August 2017

volume

10

1 reference

6 August 2017

issue

13

1 reference

6 August 2017

page(s)

2162-2171

1 reference

Eribulin induces irreversible mitotic blockade: implications of cell-based pharmacodynamics for in vivo efficacy under intermittent dosing conditions

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154365

Microtubule-binding agents: a dynamic field of cancer therapeutics

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154365

Discovery and characterization of the laulimalide-microtubule binding mode by mass shift perturbation mapping

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154365

Microtubule active agents: beyond the taxane frontier

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154365

The taccalonolides: microtubule stabilizers that circumvent clinically relevant taxane resistance mechanisms

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154365

Markers predicting clinical benefit in breast cancer from microtubule-targeting agents

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154365

Mechanisms of multidrug resistance: the potential role of microtubule-stabilizing agents

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154365

Pharmacogenetics of irinotecan metabolism and transport: an update

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154365

In vitro and in vivo anticancer activities of synthetic macrocyclic ketone analogues of halichondrin B

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154365

A common pharmacophore for cytotoxic natural products that stabilize microtubules

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154365

Structure of tubulin at 6.5 A and location of the taxol-binding site.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154365

A taxol-dependent procedure for the isolation of microtubules and microtubule-associated proteins (MAPs).

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154365

Purification of microtubules and microtubule-associated proteins from sea urchin eggs and cultured mammalian cells using taxol, and use of exogenous taxol-stabilized brain microtubules for purifying microtubule-associated proteins

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154365

New colorimetric cytotoxicity assay for anticancer-drug screening

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154365

Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154365

13 July 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.10.13.16238

Straight GDP-tubulin protofilaments form in the presence of taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.10.13.16238

Microtubule interactions with chemically diverse stabilizing agents: thermodynamics of binding to the paclitaxel site predicts cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.10.13.16238

Mitosis is not a key target of microtubule agents in patient tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.10.13.16238

mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.10.13.16238

Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCC.10.13.16238

Taccalonolides E and A: Plant-derived steroids with microtubule-stabilizing activity.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154365

27 September 2018

Identifiers

DOI

10.4161/CC.10.13.16238

1 reference

release_bgticszhhfdvlkifha2ajkckhq

6 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bgticszhhfdvlkifha2ajkckhq

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMC publication ID

3154365

1 reference

6 August 2017

1 reference